'Lung ca' presentation slideshows

P ositron E mission T omography in Clinical Oncology

P ositron E mission T omography in Clinical Oncology. Chun Ki Kim, M.D. Mount Sinai School of Medicine New York, New York. [F-18] FDG - Glucose metabolism [C-11] Methionine - Amino acid transport - Incorporation of amino acid into protein fractions

1.02k views • 89 slides

Oncologic Emergencies

Oncologic Emergencies. Jim Holliman, M.D., F.A.C.E.P. Professor of Military and Emergency Medicine Uniformed Services University of the Health Sciences Clinical Professor of Emergency Medicine George Washington University Bethesda, Maryland, U.S.A. Oncologic Emergencies

1.9k views • 75 slides

Oncologic Emergencies

Oncologic Emergencies. Oncologic Emergencies Introduction. Malignancy is 2nd leading cause of death in U.S. Now cancer has 52 % 5 year survival overall Rx of complications can be life-saving since causative tumor often is curable

910 views • 75 slides

Sepsis: still misunderstood after all these years...

918 views • 71 slides

Environmental pathology

Environmental pathology. Environmental pollution Injury by chemical agents Injury by physical agents Nutritional diseases. Environmental pollution. Air pollution smog ( sm oke+f og ) 2 types - reducing smog - coal combustion - sulfur oxides+particulates - Europe, NE USA

1.22k views • 61 slides

Environmental pathology

Environmental pathology. Environmental pollution Injury by chemical agents Injury by physical agents Nutritional diseases. Environmental pollution. Air pollution smog ( sm oke+f og ) 2 types - reducing smog - coal combustion - sulfur oxides+particulates - Europe, NE USA

636 views • 61 slides

Epidemiologic Transition: Changes of fertility and mortality with modernization

Epidemiologic Transition: Changes of fertility and mortality with modernization. Abdel Omran. The Epidemiologic Transition: A Theory of the epidemiology of population change. Milbank Quarterly. 1971;49:509-538 http://www.who.int/docstore/bulletin/pdf/2001/issue2/vol.79no.2.159-170.pdf.

736 views • 52 slides

Small Cell Lung Cancer

Small Cell Lung Cancer. Sam Wang. Outline. Small Cell Lung Cancer. SCLC - Background. SCLC Incidence: ACS 2007: All Lung CA incidence: 213,000 13% of all lung CA (~27,000). Natural History of SCLC.

1.24k views • 51 slides

Oncologic challenges in the ED

Oncologic challenges in the ED. (besides not getting the old chart from TBCC) Grand Rounds Gord McNeil. 6 Cases Approach Management Calgary perspective. Case 1.

631 views • 50 slides

Oncologic challenges in the ED

Oncologic challenges in the ED. (besides not getting the old chart from TBCC) Grand Rounds Gord McNeil. 6 Cases Approach Management Calgary perspective. Case 1.

578 views • 46 slides

Tumors of lung DR. AYSER HAMEED LEC.6

Tumors of lung DR. AYSER HAMEED LEC.6. Tumors of lung: 90-95% of lung tumors are bronchogenic carcinoma (arise from respiratory epithelium). 5% are carcinoid tumor . 2-5% are Mesenchymal tumors. Bronchogenic carcinoma Is the most common malignancy in male .

984 views • 34 slides

Lecture 3: Frequency How do we measure disease, define risks, and then make use of this information?

EPI-546 Block I. Lecture 3: Frequency How do we measure disease, define risks, and then make use of this information?. Mathew J. Reeves BVSc, PhD Associate Professor, Epidemiology. Objectives - Concepts. 1. Understand the concept of uncertainty, probability and odds

1.54k views • 29 slides

Cost Effectiveness of CT Screening in the National Lung Screening Trial

Cost Effectiveness of CT Screening in the National Lung Screening Trial. William C. Black, M.D. Dartmouth-Hitchcock Medical Center NLST CEA Writing Team. Writing Team. Methods Base case results Subset & sensitivity analyses Limitations. Outline. Comparison: LDCT, CXR, No Screen

484 views • 27 slides

Cost-Effectiveness of Screening in the National Lung Screening Trial

Cost-Effectiveness of Screening in the National Lung Screening Trial. William C. Black, MD Dartmouth-Hitchcock Medical Center. Working Group. NLST CEA. Comparison: LDCT vs CXR vs None Effectiveness: LYs and QALYs Costs: $ US (reference 2009) Perspective: Societal

283 views • 17 slides

Cost-Effectiveness of Screening in the National Lung Screening Trial

Cost-Effectiveness of Screening in the National Lung Screening Trial. William C. Black, MD Dartmouth-Hitchcock Medical Center. Working Group. NLST CEA. Comparison: LDCT vs CXR vs None Effectiveness: LYs and QALYs Costs: $ US (reference 2009) Perspective: Societal

182 views • 17 slides